Blog
RSS FeedPosted by Michael Wonder on 21 Jun 2019
Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries
21 June 2019 - Merck Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government ...
Posted by Michael Wonder on 21 Jun 2019
Price disclosure 2019 October cycle outcomes summary
21 June 2019 - The summary of price disclosure price reductions for the 2019 October Cycle has now been published on ...
Posted by Michael Wonder on 18 Jun 2019
Statement on a new effort to improve transparency and predictability for generic drug applicants to help increase timely access to high-quality, lower cost generic drugs
18 June 2019 - The U.S. FDA is committed to helping facilitate American patients’ access to lower-cost generic medicines by ...
Posted by Michael Wonder on 15 Jun 2019
Drug makers sue to block requirement for listing prices in TV ads
14 June 2019 - The rule, set to take effect 9 July, is one of the most visible efforts by the ...
Posted by Michael Wonder on 11 Jun 2019
Should the FDA disclose new filings for drugs, biologics and biosimilars?
11 June 2019 - In 2010, the FDA issued draft recommendations on increasing the transparency of the FDA’s processes and ...
Posted by Michael Wonder on 06 Jun 2019
Liberals rip Democratic leaders for writing drug pricing bill in secret
6 June 2019 - Progressive House Democrats are growing increasingly frustrated with their party’s leadership, accusing them of writing Democrats’ ...
Posted by Michael Wonder on 04 Jun 2019
Hiding in plain sight: the FDA’s approach to disclosing new drug applications is a disservice to public health
4 June 2019 - Remember in high school when a friend told you a secret and you guarded it assiduously, ...
Posted by Michael Wonder on 04 Jun 2019
Public disclosure of the filing of new drug and therapeutic biologics applications with the US Food and Drug Administration
3 June 2019 - Current regulations prohibit the US FDA from publicly disclosing the existence of pending new drug applications or ...
Posted by Michael Wonder on 28 May 2019
UK refuses to back 'game-changing' resolution on drug pricing
28 May 2019 - Global agreement urges governments to share information on actual cost of medicines, with aim of making them ...
Posted by Michael Wonder on 28 May 2019
Why adding prices to TV drug ads is bad for patients
28 May 2019 - As soon as this summer, TV ads for prescription drugs are going to look a little ...
Posted by Michael Wonder on 28 May 2019
WHO agrees watered down resolution on transparency in drug costs
28 May 2019 - World Health Organization members agreed on Tuesday to push for clearer drug pricing but stepped back ...
Posted by Michael Wonder on 27 May 2019
Trump ready to force transparency in health care pricing with an executive order
27 May 2019 - The Trump Administration wants to make it easier for patients and employers to comparison shop for ...
Posted by Michael Wonder on 27 May 2019
'You disappointed us': Why is Canada opposing more transparency in drug prices?
25 May 2019 - Pharma industry says high prices are necessary to cover costs. Some nations want to see the data. ...
Posted by Michael Wonder on 27 May 2019
Breast cancer treatments, rare disorders, venlafaxine
27 May 2019 - PHARMAC has published more information on its decisions on the funding of medicines for breast cancer, ...
Posted by Michael Wonder on 25 May 2019
Trump administration preparing executive order on health cost disclosure
24 May 2019 - Directive for price transparency could be released next week amid growing pushback against industry’s secrecy. ...